Appetite suppressants: problems and pitfalls of drug discovery
Levens, N.; Della-Zuana, O.
Current Opinion in Investigational Drugs 4(4): 384-385
2003
ISSN/ISBN: 1472-4472 PMID: 12808875 Document Number: 554378
Document emailed within 1 workday
Related Documents
Lasagna, L. 1973: Attitudes toward appetite suppressants. a survey of US physicians JAMA 225(1): 44-48Adams, C.; Cohen, A. 1999: Appetite suppressants and heart valve disorders Archives des Maladies du Coeur et des Vaisseaux 92(9): 1213-1219
2000: Valve disease and pulmonary arterial hypertension due to appetite suppressants (update) Prescrire international 9(45): 211
Glupczynski, Y.; Burette, A. 1990: Drug therapy for Helicobacter pylori infection: problems and pitfalls American Journal of Gastroenterology 85(12): 1545-1551
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Faludi, Gábor.; Gonda, Xénia.; Döme, Péter. 2015: An update on the conceptual and classification issues of anxiety, its neuroanatomy and problems of anxiolytic drug discovery Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 17(2): 69-80
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Best, J.M.; O'Shea, S.; Tipples, G.; Davies, N.; Al-Khusaiby, S.M.; Krause, A.; Hesketh, L.M.; Jin, L.; Enders, G. 2002: Interpretation of rubella serology in pregnancy--pitfalls and problems Bmj 325(7356): 147-148
Kiratli, P.O.; Gedik, G.K. 2008: Problems and pitfalls in thyroid uptake measurements with iodine-131 Hellenic Journal of Nuclear Medicine 11(3): 187-188
Williams, M. 2003: Genome-based drug discovery: prioritizing disease-susceptibility/disease-associated genes as novel drug targets for schizophrenia Current Opinion in Investigational Drugs 4(1): 31-36
Fair, W.R. 1991: Neoadjuvant therapy in invasive bladder cancer. Problems and pitfalls Urologic Clinics of North America 18(3): 539-542
Driscoll, S.G. 1987: Problems and pitfalls in the histopathologic diagnosis of gestational trophoblastic lesions Journal of Reproductive Medicine 32(9): 623-628
Donawa, M. 2000: Drug delivery systems: avoiding the pitfalls Medical Device Technology 11(6): 28-31